Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 3, Supplement 1 , Pages S10-S13 , March 2007

Industrial Medicine and Acute Musculoskeletal Rehabilitation. 2. Medications for the Treatment of Acute Musculoskeletal Pain

  • William J. Sullivan, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, University of Colorado at Denver and Health Sciences Center, Denver, CO
    • Corresponding Author InformationCorrespondence to William J. Sullivan, MD, PO Box 6508, Mailstop F-493, Aurora, CO 80045.
    • ,
  • Andre Panagos, MD

      Affiliations

    • Department of Rehabilitation Medicine, Weill Cornell Medical Center, New York–Presbyterian Hospital, New York, NY
    • ,
  • Patrick M. Foye, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry of New Jersey: New Jersey Medical School, Newark, NJ
    • ,
  • Aaron W. Sable, MD

      Affiliations

    • St. John’s Macomb Hospital, Warren, MI
    • ,
  • Robert W. Irwin, MD

      Affiliations

    • Department of Rehabilitation Medicine, University of Miami, Miller School of Medicine, Miami, FL
    • ,
  • Joseph P. Zuhosky, MD

      Affiliations

    • Total Spine Specialists, Department of Physical Medicine and Rehabilitation, Carolinas Medical Center, Charlotte, NC.

References 

  1. Key reference.

  2. Reeves RR, Algood TL, Wise PM. Skeletal muscle relaxants and associated medications for nonspecific acute back pain. P&T. 2005;30:518–524
  3. Harden RN, Argoff C. A review of three commonly prescribed skeletal muscle relaxants. J Back Musculoskeletal Rehabil. 2000;15:63–66

    ⁎

  4. Browning R, Jackson JL, O’Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Int Med. 2001;161:1613–1620
  5. Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther. 1990;12:125–131
  6. Kuehn BM. FDA panel: keep COX-2 drugs on market: black box for COX-2 labels, caution urged for all NSAIDs. JAMA. 2005;293:1571–1572
  7. US Food and Drug Administration. COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs). 2006;Available at: http://www.fda.gov/cder/drug/infopage/COX2/default.htm. Accessed June 12
  8. Oviedo JA, Wolfe MM. Gastroprotection by coxibs: what do the Celecoxib Long-Term Arthritis Safety Study and the Vioxx Gastrointestinal Outcomes Research Trial tell us?. Rheum Dis Clin N Am. 2003;29:769–788
  9. Hawkey C, Kahan A, Steinbruck K, et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment [published erratum in: Br J Rheumatol 1998;37:1142]. Br J Rheumatol. 1998;37:937–945
  10. Weideman RA, Kelly KC, Kazi S, et al. Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis. Gastroenterology. 2004;127:1322–1328
  11. Micklewright R, Lane S, Linley W, McQuade C, Thompson F, Maskrey N. Review article: NSAIDs, gastroprotections and cyclo-oxygenase-II-selective inhibitors. Aliment Pharmacol Ther. 2003;17:321–332

    ⁎

  12. Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Physician. 2005;71:913–918

    ⁎

  13. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev. 2003;55:1–20
  14. Benoist JL, Gammaitoni AR. The 5% lidocaine patch reduces pain intensity in professional athletes with sports injury pain without significant systemic effects or cognitive and performance impairment [abstract]. Arch Phys Med Rehabil. 2005;86:E34
  15. Ridgway D. Analgesics for acute pain: meeting the United States Food and Drug Administration’s requirements for proof of efficacy. Clin J Pain. 2004;20:123–132

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

 Reprints are not available from the author.

PII: S0003-9993(06)01564-4

doi: 10.1016/j.apmr.2006.12.009

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 3, Supplement 1 , Pages S10-S13 , March 2007

Article Tools